Accelerate Diagnostics Gross Margin 2010-2024 | AXDXQ
Current and historical gross margin for Accelerate Diagnostics (AXDXQ) over the last 10 years. The current gross profit margin for Accelerate Diagnostics as of December 31, 2024 is %.
| Accelerate Diagnostics Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $0.01B | $0.00B | 25.00% |
| 2024-09-30 | $0.01B | $0.00B | 33.33% |
| 2024-06-30 | $0.01B | $0.00B | 25.00% |
| 2024-03-31 | $0.01B | $0.00B | 25.00% |
| 2023-12-31 | $0.01B | $0.00B | 25.00% |
| 2023-09-30 | $0.01B | $0.00B | 25.00% |
| 2023-06-30 | $0.01B | $0.00B | 33.33% |
| 2023-03-31 | $0.01B | $0.00B | 30.77% |
| 2022-12-31 | $0.01B | $0.00B | 30.77% |
| 2022-09-30 | $0.01B | 0 | 0.00% |
| 2022-06-30 | $0.01B | 0 | 0.00% |
| 2022-03-31 | $0.01B | 0 | 0.00% |
| 2021-12-31 | $0.01B | 0 | 0.00% |
| 2021-09-30 | $0.01B | $0.00B | 33.33% |
| 2021-06-30 | $0.01B | $0.00B | 30.77% |
| 2021-03-31 | $0.01B | $0.00B | 33.33% |
| 2020-12-31 | $0.01B | $0.00B | 36.36% |
| 2020-09-30 | $0.01B | $0.01B | 45.45% |
| 2020-06-30 | $0.01B | $0.01B | 55.56% |
| 2020-03-31 | $0.01B | $0.01B | 55.56% |
| 2019-12-31 | $0.01B | $0.01B | 55.56% |
| 2019-09-30 | $0.01B | $0.00B | 50.00% |
| 2019-06-30 | $0.01B | $0.00B | 57.14% |
| 2019-03-31 | $0.01B | $0.00B | 57.14% |
| 2018-12-31 | $0.01B | $0.00B | 50.00% |
| 2018-09-30 | $0.01B | $0.00B | 50.00% |
| 2018-06-30 | $0.01B | $0.00B | 50.00% |
| 2018-03-31 | $0.01B | $0.00B | 60.00% |
| 2017-12-31 | $0.01B | $0.00B | 80.00% |
| 2017-09-30 | $0.00B | $0.00B | 100.00% |
| 2017-06-30 | $0.00B | $0.00B | 100.00% |
| 2017-03-31 | $0.00B | $0.00B | 100.00% |
| 2016-12-31 | $0.00B | 0 | 0.00% |
| 2016-09-30 | $0.00B | 0 | 0.00% |
| 2016-06-30 | $0.00B | 0 | 0.00% |
| 2016-03-31 | $0.00B | 0 | 0.00% |
| 2015-12-31 | $0.00B | 0 | 0.00% |
| 2015-09-30 | $0.00B | 0 | 0.00% |
| 2015-06-30 | $0.00B | 0 | 0.00% |
| 2015-03-31 | $0.00B | 0 | 0.00% |
| 2014-12-31 | $0.00B | 0 | 0.00% |
| 2014-09-30 | $0.00B | 0 | 0.00% |
| 2014-06-30 | $0.00B | 0 | 0.00% |
| 2014-03-31 | $0.00B | 0 | 0.00% |
| 2013-12-31 | $0.00B | 0 | 0.00% |
| 2013-06-30 | $0.00B | 0 | 0.00% |
| 2013-03-31 | $0.00B | 0 | 0.00% |
| 2012-10-31 | $0.00B | 0 | 0.00% |
| 2012-09-30 | $0.00B | 0 | 0.00% |
| 2012-06-30 | $0.00B | 0 | 0.00% |
| 2012-04-30 | $0.00B | 0 | 0.00% |
| 2012-01-31 | $0.00B | 0 | 0.00% |
| 2011-10-31 | $0.00B | 0 | 0.00% |
| 2011-01-31 | $0.00B | 0 | 0.00% |
| 2010-10-31 | $0.00B | 0 | 0.00% |
| 2010-01-31 | $0.00B | 0 | 0.00% |
| 2009-10-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.152B | 75.93 |
| Thermo Fisher Scientific (TMO) | United States | $161.424B | 19.53 |
| Edwards Lifesciences (EW) | United States | $44.758B | 29.35 |
| Alcon (ALC) | Switzerland | $43.731B | 29.55 |
| IDEXX Laboratories (IDXX) | United States | $42.784B | 49.17 |
| DexCom (DXCM) | United States | $33.376B | 51.59 |
| IQVIA Holdings (IQV) | United States | $32.417B | 18.00 |
| Mettler-Toledo (MTD) | United States | $25.333B | 30.13 |
| STERIS (STE) | Ireland | $22.005B | 24.24 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.444B | 0.00 |
| Waters (WAT) | United States | $17.106B | 24.14 |
| Hologic (HOLX) | United States | $14.567B | 15.83 |
| Sysmex ADR (SSMXY) | Japan | $10.191B | 28.91 |
| Penumbra (PEN) | United States | $8.980B | 70.48 |
| Masimo (MASI) | United States | $8.579B | 31.65 |
| Globus Medical (GMED) | United States | $7.176B | 17.10 |
| Glaukos (GKOS) | United States | $5.506B | 0.00 |
| Teleflex (TFX) | United States | $5.091B | 8.40 |
| Integer Holdings (ITGR) | United States | $3.989B | 20.90 |
| TransMedics (TMDX) | United States | $3.572B | 77.65 |
| PROCEPT BioRobotics (PRCT) | United States | $3.251B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.375B | 14.14 |
| Nihon Kohden (NHNKY) | Japan | $2.079B | 23.85 |
| Elekta AB (EKTAY) | Sweden | $1.899B | 17.07 |
| Veracyte (VCYT) | United States | $1.841B | 25.83 |
| Alphatec Holdings (ATEC) | United States | $1.570B | 0.00 |
| Artivion (AORT) | United States | $1.298B | 121.60 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.020B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.020B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.936B | 4.98 |
| SiBone (SIBN) | United States | $0.731B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 36.32 |
| Beta Bionics (BBNX) | United States | $0.649B | 0.00 |
| AxoGen (AXGN) | United States | $0.571B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.554B | 11.93 |
| OrthoPediatrics (KIDS) | United States | $0.553B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.547B | 8.51 |
| Pacific Biosciences Of California (PACB) | United States | $0.486B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.435B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.393B | 9.13 |
| Delcath Systems (DCTH) | United States | $0.386B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.314B | 0.00 |
| NeuroPace (NPCE) | United States | $0.307B | 0.00 |
| RxSight (RXST) | United States | $0.295B | 0.00 |
| Neuronetics (STIM) | United States | $0.279B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.259B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.07 |
| CVRx (CVRX) | United States | $0.210B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.204B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.185B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.169B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.167B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.161B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 45.00 |
| Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
| Spectral AI (MDAI) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.31 |